Terns Pharmaceuticals, Inc. (TERN)
52.61
-0.02
(-0.04%)
USD |
NASDAQ |
Apr 13, 16:00
52.55
-0.06
(-0.11%)
After-Hours: 17:21
Terns Pharmaceuticals Cash from Investing (TTM) : -298.04M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Merck & Co., Inc. | -13.74B |
| Corcept Therapeutics, Inc. | 69.76M |
| Cogent Biosciences, Inc. | -399.53M |
| BioMarin Pharmaceutical, Inc. | -414.24M |
| ADMA Biologics, Inc. | -21.89M |